Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|May 9, 2008
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphomaPaul L R Mitchell, Paula Marlton, Andrew Grigg, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|July 19, 2005
Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error ratesEmmanuel J Favaloro, Roslyn Bonar, Geoff Kershaw, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2018
A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03)Andrew Wirth, H Miles Prince, Daniel Roos, et al.
American Journal of Clinical Pathology|August 7, 2002
Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methodsSusan E Rodgers, Nancy V Lerda, Emmanuel J Favaloro, et al.
Leukemia & Lymphoma|September 13, 2019
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantationMaansi Joshi, John Taper, Cecily Forsyth, et al.
Leukemia & Lymphoma|November 24, 2022
Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient ProgramStephen P Mulligan, Stephen Opat, Chan Y Cheah, et al.
Leukemia & Lymphoma|June 9, 2016
Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML)Melita Kenealy, Nigel Patton, Robin Filshie, et al.
Journal of Medical Imaging and Radiation Oncology|March 27, 2018
Impact of salvage treatment modalities in patients with positive FDG-PET/CT after R-CHOP chemotherapy for aggressive B-cell non-Hodgkin lymphomaVicky Chin, Michael Fulham, Mark Hertzberg, et al.
Journal of Psychosocial Oncology|January 20, 2021
Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivorsLisa Brice, Nicole Gilroy, Gemma Dyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myelomaMark A Dawson, Stephen S Opat, Yamna Taouk, et al.
Pageof 9